Food and Drug Administration is cracking down on telehealth companies for making false and misleading claims about compounded versions of popular weight loss drugs, GLP-1s
Weight regain after stopping GLP-1 analogue treatment is possible if healthy lifestyle habits are not maintained
10.1016/j.clinthera.2015.01.003 14 LuN.SunH.YuJ.WangX.LiuD.ZhaoL.et al (2015)
In laboratory preclinical studies, these drugs help reduce harmful protein clumps in the brain
Clinical trial data show that gastrointestinal adverse effectsincluding nausea, vomiting, diarrhea, and abdominal discomfortoccur in 20-50% of patients initiating GLP-1 therapy, with rates varying by specific agent and dose
It is important to recognize that the cardiovascular and renal benefits of GLP-1 medications typically outweigh the potential for retinopathy progression in appropriately selected patients, and discontinuing these medications due to unfounded concerns about vision may result in worse overall health outcomes